Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

We are a global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies.

Our Unique Position

  • World leader in ADC contract development and manufacturing
  • World-class facilities in the UK and US, backed by a highly experienced team
  • Integrated services from conjugation development to clinical and commercial GMP batch manufacturing and sterile fill/finish
  • 98% GMP batch success rate
  • ADC Grangemouth Site is successfully audited by US FDA, UK MHRA, Brazil ANVISA, Japan PMDA

Antibody Drug Conjugation

Shanghai, China - Sourcing Office Note: *Through PPS Minority Investment in Yapan Bio